Recently Viewed
Clear All$55.52
$0.76
(1.39%)
As on 02-Apr-2026 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$2,163 Mln
Revenue (TTM)
$1,464 Mln
Net Profit (TTM)
$0 Mln
ROE
0.3 %
ROCE
-- %
P/E Ratio
23.6
P/B Ratio
6.2
Industry P/E
24.51
EV/EBITDA
12.7
Div. Yield
0.9 %
Debt to Equity
2.1
Book Value
$--
EPS
$2.3
Face value
--
Shares outstanding
20,623,682
CFO
$473.40 Mln
EBITDA
$923.95 Mln
Net Profit
$493.80 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Phibronimal Health Corporation Class A (PAHC)
| 48.6 | 1.7 | 48.6 | 152.7 | 53.6 | 17.3 | 7.3 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Phibronimal Health Corporation Class A (PAHC)
| 77.9 | 80.5 | -13.6 | -34.3 | 5.1 | -21.8 | -22.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Phibronimal Health Corporation Class A (PAHC)
|
55.5 | 2,162.5 | 1,464.3 | 92.1 | 12.0 | 29.8 | 23.6 | 6.2 |
| 12.5 | 3,812.0 | 3,018.8 | 72.1 | 12.6 | -80 | 54.3 | 86.1 | |
| 168.5 | 8,210.1 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 92.9 | |
| 73.2 | 13,446.3 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 42.5 | 4,055.0 | 761.4 | 99.7 | 7.3 | 15 | 46.5 | 5.7 | |
| 13.3 | 11,237.7 | 345,831.0 | 56,586.0 | 21.5 | 15.8 | 18.7 | 2.9 | |
| 23.1 | 11,474.6 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.8 | |
| 8.2 | 7,645.3 | 7,227.1 | 386.1 | 16.6 | 6.9 | 13.8 | 0.9 | |
| 199.6 | 3,841.5 | 268.1 | 124.5 | 60.0 | 13.5 | 31.5 | 4.0 | |
| 37.7 | 3,099.9 | 158.3 | -68.9 | -29.3 | -113 | -- | 69.3 |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health,... Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey. Address: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 Read more
Chairman, President & CEO
Mr. Jack Clifford Bendheim
Chairman, President & CEO
Mr. Jack Clifford Bendheim
Headquarters
Teaneck, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Phibro Animal Health Corporation Class A (PAHC) is $55.52 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Phibro Animal Health Corporation Class A (PAHC) has given a return of 53.6% in the last 3 years.
The P/E ratio of Phibro Animal Health Corporation Class A (PAHC) is 23.61 times as on 31-Mar-2026, a 4 discount to its peers’ median range of 24.51 times.
The P/B ratio of Phibro Animal Health Corporation Class A (PAHC) is 6.19 times as on 31-Mar-2026, a 9 premium to its peers’ median range of 5.66 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.54
|
3.64
|
|
2024
|
281.27
|
2.65
|
|
2023
|
17.02
|
1.96
|
|
2022
|
15.76
|
2.95
|
|
2021
|
21.51
|
4.90
|
The 52-week high and low of Phibro Animal Health Corporation Class A (PAHC) are Rs 57.62 and Rs 16.16 as of 04-Apr-2026.
Phibro Animal Health Corporation Class A (PAHC) has a market capitalisation of $ 2,163 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Phibro Animal Health Corporation Class A (PAHC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.